Furthermore, the expression of FMO3 in subcutaneous white adipose tissue was found to be positively associated with obesity in mice and humans, and FMO3 was identified as a negative regulator of the beiging of white adipose tissue (Schugar et al., 2017). Here, FMO3 is linked to obesity disorder.